A meningococcal vaccine antigen engineered to increase thermal stability and stabilize protective epitopes
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A meningococcal vaccine antigen engineered to increase thermal stability and stabilize protective epitopes
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 112, Issue 48, Pages 14823-14828
Publisher
Proceedings of the National Academy of Sciences
Online
2015-11-17
DOI
10.1073/pnas.1507829112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Binding of Complement Factor H (FH) Decreases Protective Anti-FH Binding Protein Antibody Responses of Infant Rhesus Macaques Immunized With a Meningococcal Serogroup B Vaccine
- (2015) Dan M. Granoff et al. JOURNAL OF INFECTIOUS DISEASES
- Human Factor H (FH) Impairs Protective Meningococcal Anti-FHbp Antibody Responses and the Antibodies Enhance FH Binding
- (2014) I. Costa et al. mBio
- Importance of Inhibition of Binding of Complement Factor H for Serum Bactericidal Antibody Responses to Meningococcal Factor H-binding Protein Vaccines
- (2013) Monica Konar et al. JOURNAL OF INFECTIOUS DISEASES
- Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen
- (2013) Enrico Malito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice
- (2013) Raffaella Rossi et al. VACCINE
- Design of Meningococcal Factor H Binding Protein Mutant Vaccines That Do Not Bind Human Complement Factor H
- (2012) Rolando Pajon et al. INFECTION AND IMMUNITY
- A Broadly Cross-Reactive Monoclonal Antibody Against an Epitope on the N-terminus of Meningococcal fHbp
- (2012) David M. Vu et al. Scientific Reports
- The Effect of Human Factor H on Immunogenicity of Meningococcal Native Outer Membrane Vesicle Vaccines with Over-Expressed Factor H Binding Protein
- (2012) Peter T. Beernink et al. PLoS Pathogens
- Design and Evaluation of Meningococcal Vaccines through Structure-Based Modification of Host and Pathogen Molecules
- (2012) Steven Johnson et al. PLoS Pathogens
- Structure of the uncomplexedNeisseria meningitidisfactor H-binding protein fHbp (rLP2086)
- (2011) Laura Cendron et al. Acta Crystallographica Section F-Structural Biology and Crystallization Communications
- A Meningococcal Factor H Binding Protein Mutant That Eliminates Factor H Binding Enhances Protective Antibody Responses to Vaccination
- (2011) P. T. Beernink et al. JOURNAL OF IMMUNOLOGY
- Rational Design of a Meningococcal Antigen Inducing Broad Protective Immunity
- (2011) M. Scarselli et al. Science Translational Medicine
- Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States
- (2011) Xin Wang et al. VACCINE
- Meningococcal Factor H Binding Proteins in Epidemic Strains from Africa: Implications for Vaccine Development
- (2011) Rolando Pajon et al. PLoS Neglected Tropical Diseases
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Impaired Immunogenicity of a Meningococcal Factor H-Binding Protein Vaccine Engineered To Eliminate Factor H Binding
- (2010) P. T. Beernink et al. Clinical and Vaccine Immunology
- Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy
- (2010) Jamie Findlow et al. CLINICAL INFECTIOUS DISEASES
- Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
- (2010) Han-Qing Jiang et al. VACCINE
- Sequence Diversity of the Factor H Binding Protein Vaccine Candidate in Epidemiologically Relevant Strains of Serogroup BNeisseria meningitidis
- (2009) Ellen Murphy et al. JOURNAL OF INFECTIOUS DISEASES
- Meningococcal Factor H–Binding Protein Variants Expressed by Epidemic Capsular Group A, W‐135, and X Strains from Africa
- (2009) P. T. Beernink et al. JOURNAL OF INFECTIOUS DISEASES
- The modular architecture of meningococcal factor H-binding protein
- (2009) P. T. Beernink et al. MICROBIOLOGY-SGM
- Variation of the factor H-binding protein of Neisseria meningitidis
- (2009) C. Brehony et al. MICROBIOLOGY-SGM
- A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups
- (2009) Peter T. Beernink et al. MOLECULAR IMMUNOLOGY
- Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates
- (2009) Muriel C. Schneider et al. NATURE
- A RANDOMIZED, DOUBLE-BLIND STUDY EXAMINING THE COMPARATIVE EFFICACIES AND SAFETY OF INHALED EPINEPHRINE AND NASAL DECONGESTANT IN HOSPITALIZED INFANTS WITH ACUTE BRONCHIOLITIS
- (2009) Gilat Livni et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates
- (2009) Rolando Pajon et al. VACCINE
- Meningococcal Outer Membrane Vesicle Vaccines Derived from Mutant Strains Engineered To Express Factor H Binding Proteins from Antigenic Variant Groups 1 and 2
- (2008) O. Koeberling et al. Clinical and Vaccine Immunology
- Bactericidal Antibody Responses Induced by Meningococcal Recombinant Chimeric Factor H-Binding Protein Vaccines
- (2008) P. T. Beernink et al. INFECTION AND IMMUNITY
- Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086
- (2008) Alessandro Mascioni et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation